THE PREDICTIVE VALUE OF BODY MASS INDEX AND MAYO ADHESIVE PROBABILITY SCORE IN SURGICAL OUTCOMES AND THEIR ROLE IN SURGICAL CONVERSION IN PATIENTS WITH CLINICAL STAGE I RENAL CELL CARCINOMA

被引：0
|
作者：
Tena-Gonzalez Mendez, Gerardo
Gonzalez-Sanchez, Benjamin
Kauffman-Ortega, Christopher
Garza-Gangemi, Adrian M.
Manzanilla-Romero, Hector
Toledo, Vicente
Rodriguez-Covarrubias, Francisco
Gabilondo-Pliego, Bernardo
Gabilondo-Navarro, Fernando
机构：
来源：
JOURNAL OF UROLOGY | 2020年 / 203卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP68-20
引用
收藏
页码：E1043 / E1043
页数：1
相关论文
共 50 条
  • [41] Impact of Body Mass Index on Survival Outcomes of Patients with Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: A Systematic Review and Meta-analysis
    Takemura, Kosuke
    Yonekura, Satoru
    Downey, Laura E.
    Evangelopoulos, Dimitris
    Heng, Daniel Y. C.
    EUROPEAN UROLOGY OPEN SCIENCE, 2022, 39 : 62 - 71
  • [42] CLINICAL CHARACTERISTICS, PERIOPERATIVE AND ONCOLOGICAL OUTCOMES FOLLOWING SURGICAL TREATMENT FOR RENAL CELL CARCINOMA IN PATIENTS ≤40 YEARS: DATA FROM THE LATIN AMERICAN RENAL CANCER GROUP (LARCG)
    Garza-Gangemi, Adrian
    Castillejos-Molina, Ricardo A.
    Nolazco, Alejandro
    Campos-Salcedo, Jose
    Bravo, Edgar
    Tobia, Ignacio
    Maria Autran-Gomez, Ana
    Palou, Joan
    Abreu-Clavijo, Diego
    Zequi, Stenio de Cassio
    Rodriguez-Covarrubias, Francisco
    JOURNAL OF UROLOGY, 2020, 203 : E68 - E68
  • [43] Baseline levels of proinflammatory cytokines according to body mass index (BMI) and BMI impact on clinical outcomes in metastatic renal cell carcinoma (mRCC) patients (pts) treated with nivolumab (NIVO) within the NIVOREN trial
    Colomba, E.
    Ajuria, L. Carril
    Dalban, C.
    Derosa, L.
    Silva, C. Alves Costa
    Rassy, E.
    Negrier, S.
    Chevreau, C. M.
    Mescam, G. Gravis
    Oudard, S.
    Laguerre, B.
    Barthelemy, P.
    Goupil, M. Gross
    Geoffrois, L.
    Thiery-Vuillemin, A.
    Lobbedez, F. Joly
    Ladoire, S.
    Tantot, F.
    Escudier, B.
    Albiges, L.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1223 - S1224
  • [44] Comparison of the outcomes of stereotactic body radiotherapy versus surgical treatment for elderly (≥70) patients with early-stage non-small cell lung cancer after propensity score matching
    Baiqiang Dong
    Jin Wang
    Xuan Zhu
    Yuanyuan Chen
    Yujin Xu
    Kainan Shao
    Lei Zheng
    Hangjie Ying
    Ming Chen
    Jianping Cao
    Radiation Oncology, 14
  • [45] Comparison of the outcomes of stereotactic body radiotherapy versus surgical treatment for elderly (≥70) patients with early-stage non-small cell lung cancer after propensity score matching
    Dong, Baiqiang
    Wang, Jin
    Zhu, Xuan
    Chen, Yuanyuan
    Xu, Yujin
    Shao, Kainan
    Zheng, Lei
    Ying, Hangjie
    Chen, Ming
    Cao, Jianping
    RADIATION ONCOLOGY, 2019, 14 (01)
  • [46] Influence of Body Mass Index, Smoking, and Blood Pressure on Survival of Patients with Surgically-Treated, Low Stage Renal Cell Carcinoma: A 14-Year Retrospective Cohort Study
    Park, Bumsoo
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Choi, Han Yong
    Lee, Hyun Moo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2013, 28 (02) : 227 - 236
  • [47] Predictive value of preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio combined with operating room factors for surgical site infection after laparoscopic radical nephrectomy in renal cell carcinoma patients
    Shen, Jun
    Xie, Xun
    Meng, Yonghui
    Mu, Youyou
    INTERNATIONAL WOUND JOURNAL, 2024, 21 (01)
  • [48] Impact of pretreatment body mass index on clinical outcomes in patients with metastatic renal cell carcinoma receiving first-line immune checkpoint inhibitor-based therapy: A systematic review and meta-analysis
    Lee, Kunwoo
    Yu, Jiwoong
    Song, Wan
    Sung, Hyun Hwan
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Kang, Minyong
    INVESTIGATIVE AND CLINICAL UROLOGY, 2024, 65 (05) : 423 - 434
  • [49] Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)
    Santoni, Matteo
    Massari, Francesco
    Myint, Zin W.
    Iacovelli, Roberto
    Pichler, Martin
    Basso, Umberto
    Kopecky, Jindrich
    Kucharz, Jakub
    Buti, Sebastiano
    Salfi, Alessia
    Buettner, Thomas
    De Giorgi, Ugo
    Kanesvaran, Ravindran
    Fiala, Ondrej
    Grande, Enrique
    Zucali, Paolo Andrea
    Fornarini, Giuseppe
    Bourlon, Maria T.
    Scagliarini, Sarah
    Molina-Cerrillo, Javier
    Aurilio, Gaetano
    Matrana, Marc R.
    Pichler, Renate
    Cattrini, Carlo
    Buechler, Tomas
    Seront, Emmanuel
    Calabro, Fabio
    Pinto, Alvaro
    Berardi, Rossana
    Zgura, Anca
    Mammone, Giulia
    Ansari, Jawaher
    Atzori, Francesco
    Chiari, Rita
    Zakopoulou, Roubini
    Caffo, Orazio
    Procopio, Giuseppe
    Bassanelli, Maria
    Zampiva, Ilaria
    Messina, Carlo
    Kueronya, Zsofia
    Mosca, Alessandra
    Bhuva, Dipen
    Vau, Nuno
    Incorvaia, Lorena
    Rebuzzi, Sara Elena
    Roviello, Giandomenico
    Zabalza, Ignacio Ortego
    Rizzo, Alessandro
    Mollica, Veronica
    CLINICAL GENITOURINARY CANCER, 2023, 21 (05) : E309 - U12
  • [50] Body mass index as independent predictor of overall survival in patients with advanced renal cell carcinoma at start of systemic treatment-Analyses from the German clinical RCC-Registry
    Goebell, Peter J.
    Mueller, Lothar
    Huebner, Andreas
    Harich, Hanns-Detlev
    Boller, Emil
    Koska, Michaela
    Jaenicke, Martina
    Marschner, Norbert
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (10) : 470.e1 - 470.e9
12345